Clinical Trials on Cancer of Head and Neck in France

Total 6994 results

Bristol-Myers Squibb

Active, not recruiting

A Study of Nivolumab in Patients With Head and Neck Cancer. (ProNiHN)

Squamous Cell Carcinoma of the Head and Neck; Head and Neck Cancer; Head and Neck Carcinoma; Cancer of the Head and Neck

France
University Hospital, Brest

Completed

Prognostic Value of 18FDG PET/CT Textural Indices in HNSCC (ImpactTextureO)

Cancer of Head and Neck

France
Groupe Oncologie Radiotherapie Tete et Cou
Centre Leon Berard

Active, not recruiting

Trial Evaluating Adapted Chemotherapy in Patients With Squamous Carcinoma (TPFmORL)

Cancer of Head and Neck

France
University Hospital, Brest

Completed

Forecasts Impact of the Pre-therapeutic TEP-TDM in the 18-FDG Restaging of Upper Aero-digestive Tract Cancers (RENOVATE)

Cancer of Head and Neck

France
Centre Hospitalier Universitaire, Amiens

Recruiting

Nutritional Course of Care After Surgical Treatment at the Patients Affected by a Cancer of the Head and by the Neck (NUTRIMAX)

Head and Neck Cancer | Nutrition Disorders

France
University Hospital, Bordeaux

Completed

Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer (MISORL)

Head and Neck Neoplasms | Cancer of Head and Neck

France
Centre Leon Berard

Recruiting

Lung Ultrasound Score After ENT Cancer Surgery (LUSENT)

Tracheostomy | Surgery | Cancer of Head and Neck | Postoperative Pulmonary Complication

France
University Hospital, Caen
University Hospital, Rouen; Centre Francois Baclesse

Terminated

Nutrition and Quality of Life of Patients With Head and Neck Carcinoma After Radiotherapy (NUQUE3)

Head and Neck Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Study of a Simplified Geriatric Evaluation Performed by Oncologists Prior to Cancer Treatment by Radiotherapy or Chemotherapy in Subjects Aged 70 Years or Older With Inoperable Squamous Cell Cancer of the Head and Neck (ELAN-ONCOVAL)

Inoperable Squamous Cell Cancer of the Head and Neck

France
Sanofi

Completed

Phase II Study of Oxaliplatin in Combination With 5-Fu in 1st Line Treatment of Locally Advanced or Metastatic Squamous Cell Carcinoma of the Head and Neck

Head and Neck Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Reirradiation With Concomitant Chemotherapy After Salvage Surgery for Recurrence of Head and Neck Cancer in Irradiated Area

Recurrence of Head and Cancer in Irraiated Area

France
Centre Francois Baclesse
Ministry of Health, France

Completed

Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With Radiotherapy (IPAC)

Head and Neck Cancer

France
Centre Francois Baclesse

Recruiting

Interest of Bilateral Basic Tongue Mucosectomy Assisted by Robot or Laser in Combination With Tonsillectomy in the Assessment of Prevalent Cervical Lymphadenopathy (RoboCUP)

Cancer of Head and Neck | Adenopathy

France
Centre Hospitalier Universitaire de Besancon
Roche Pharma AG; National Cancer Institute, France

Active, not recruiting

Combination of UCPVax Vaccine and Atezolizumab for the Treatment of Human Papillomavirus Positive Cancers (VolATIL) (VolATIL)

Cervical Cancer | Squamous Cell Carcinoma of the Head and Neck | Anal Canal Cancer

France
Sai-Hong Ignatius Ou
Sanofi

Terminated

Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer

Cancer of the Head and Neck

United States
Central Hospital, Nancy, France

Unknown

Anti-tumor Specific Immune Response in Head and Neck Cancers (CORISAT)

Head and Neck Squamous Cell Carcinoma

France
PCI Biotech AS

Terminated

A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.

Recurrent Head and Neck Cancer | Carcinoma, Squamous Cell of Head and Neck

Germany, United Kingdom, France, Lithuania, Netherlands, Poland
Assistance Publique Hopitaux De Marseille

Completed

Pharmacokinetics and Pharmacogenetics-based Adaptive Dosing of 5-fu (5-Fluorouracile) in Head & Neck Cancer Patient Undergoing Docetaxel, Cisplatin, 5-Fluorouracile (=TPF) Therapy (5-FU)

Patients With Head and Neck Cancer (ORL)

France
Centre Hospitalier Universitaire, Amiens

Not yet recruiting

Intratumoral Gemcitabine, Paclitaxel, Carboplatine and Intravenous Nivolumab for Locally Recurrence of Head and Neck Cancers (NIVOCHIMLOC)

Squamous Cell Carcinoma of the Head and Neck | Paclitaxel | Nivolumab | Carboplatin

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Effect of the Rehabilitation Effort at Home in Patients With Head and Neck Tumor Treated With Curative Intent (NUTRIMOUV)

Head and Neck Cancer

France
Institut de cancérologie Strasbourg Europe
Institut National de la Santé Et de la Recherche Médicale, France; Centre National...

Recruiting

Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma (IPRICE)

Head and Neck Cancer

France
Assistance Publique - Hôpitaux de Paris
Cancer Research and Personalized Medicine (Carpem); Laboratoire d'excellence...

Unknown

Potentiation of Cisplatin-based Chemotherapy by Digoxin in Advanced Unresectable Head and Neck Cancer Patients (DIGHANC)

Head and Neck Cancer

France
Centre Oscar Lambret

Unknown

Radiotherapy in Association With Cetuximab in Patients Treated for an Epidermoid Cancer

Epidermoid Head and Neck Cancer

France
Institut Claudius Regaud
University Hospital, Caen; Centre Francois Baclesse; Onco-Occitanie (Toulouse)

Completed

FALCOn (Facteur AnthropoLogique Cancer Orl) (FALCOn)

Head and Neck Cancer | Head and Neck Carcinoma

France
Hospices Civils de Lyon

Completed

DNA Repair Enzyme Signature in Head and Neck Cancer (CHEMRAD) (CHEMRAD)

Head Cancer | Neck Cancer

France
UNICANCER

Completed

A Phase II, Open-Label, Multicenter Trial of Cabazitaxel in Patients With Recurrent or Metastatic Head and Neck Cancer After Failure Of Cisplatin, Cetuximab and Taxanes (ORL03)

Recurrent Head and Neck Cancer | Metastatic Head and Neck Cancer

France
CHU de Reims

Completed

Pancreatico-biliary Tumor Mutation Profiling in Bile Samples (ONCOBIL)

Cholangiocarcinoma, Cancer of the Head of the Pancreas

France
Gustave Roussy, Cancer Campus, Grand Paris

Active, not recruiting

Evaluation of the Contribution of Transoral Robotic-assisted Surgery Using Da Vinci Xi for Head and Neck Tumors (TORS)

Head and Neck Cancer

France
Gustave Roussy, Cancer Campus, Grand Paris
National Cancer Institute, France

Unknown

Durvalumab in Combination With Docetaxel, Cisplatin and 5-FU for Locally Advanced Head and Neck Squamous Cell Carcinoma (MEDINDUCTION)

Head and Neck Cancers

France
Groupe Oncologie Radiotherapie Tete et Cou

Completed

Reirradiation and Erbitux in the HNSCC

Head and Neck Cancer Squamous Cell

France
Centre Antoine Lacassagne

Recruiting

Conventional Oxygen Therapy Versus Continuous Transnasal High Flow Oxygen Therapy for Head and Neck Diagnostic Panendoscopy Under General Anesthesia in Spontaneous Ventilation (OPTINOSE)

Head and Neck Cancer

France
Centre Francois Baclesse

Recruiting

Establishment of Squamous Cell Organoids of the Head and Neck to Assess Their Response to Innovative Therapies (ORGAVADS)

Head and Neck Cancer

France
University Hospital Center of Martinique
European Georges Pompidou Hospital

Completed

Changes in the Microenvironment of HPV-induced Head and Neck Cancers in West Indies and Metropolitan Population (MituHPV)

Immunotherapy

France, Martinique
GCS Ramsay Santé pour l'Enseignement et la Recherche

Recruiting

Profiles of Expression in HPV+ Versus HPV Head and Neck Cancers (HPVNGS)

Head and Neck Cancer

France
Centre Henri Becquerel

Recruiting

Benefit of Paramedical Care in Accompanying Caregivers of Patients That Had Surgery for an Head and Neck Invasive Cancer (AIDORL)

Head and Neck Cancer

France
Centre Francois Baclesse
Ligue contre le cancer, France; Fondation de France; Centre National de la Recherche...

Recruiting

Circulating Immunes Cells, Cytokines and Brain Radiotherapy (CYRAD)

Head and Neck Cancer

France
Centre Henri Becquerel

Completed

Nutritional Status Assessment in Head and Neck Cancer Patients Receiving Radiotherapy or Chemo-radiotherapy (NUTRINECK)

Head and Neck Cancer

France
Hospices Civils de Lyon

Completed

Free Flaps : Should we Propose Them to the Elderly ?

Head and Neck Cancer

France
EMD Serono

Completed

EMD 1201081 in Combination With Cetuximab in Second-Line Cetuximab-Naïve Subjects With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Squamous Cell Carcinoma of the Head and Neck Cancer

Czech Republic, France, United Kingdom, Belgium, Hungary, United States, Poland, Slovakia
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Comparison of Tumor Glucose Metabolism Before and After Artificial Nutrition (PETANC)

Head and Neck Cancer | Oesophageal Cancer

France
University Hospital, Toulouse

Recruiting

Impact in Head and Neck Oncology of Support by a Nurse in the Patient's Care Pathway (COACH-ORL)

Head and Neck Cancer

France
Institut Claudius Regaud

Withdrawn

Evaluation of the Automatic Deformable Recontouring on the Daily MVCT for Head and Neck Cancer Adaptive Radiotherapy (GIRAFE)

Head and Neck Cancer

France
Groupe Oncologie Radiotherapie Tete et Cou
AstraZeneca

Terminated

Post-operative Radiotherapy With Cisplatin Alone or in Combination With Iressa in Upper Aerodigestive Tract Carcinomas

Head and Neck Cancer

France
Groupe Oncologie Radiotherapie Tete et Cou

Recruiting

Study Comparing RT With Cetuximab + Xevinapant to RT With Cetuximab-placebo in Patients With Head and Neck Cancer (XXL_2022-01)

Squamous Cell Carcinoma of the Head and Neck

France
Pierre Fabre Medicament

Completed

Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer

Recurrent or Metastatic Head and Neck Carcinoma

France
Hospices Civils de Lyon

Completed

SOMESThesia and ALIMentation (SOMEST'ALIM)

Head and Neck Cancer

France
Centre Hospitalier Universitaire, Amiens
Regional Council Picardie

Completed

Monitoring of Bone Free Flaps With Microdialysis (MTM)

Head and Neck Cancer | Microsurgery | Head and Neck Reconstructive Surgery | Head and/or Neck Shotgun Trauma | Bone Free Flap

France
Weprom
Neptune

Active, not recruiting

Prophylaxis of Magnesium-rich Mineral Water to Prevent Hypomagnesemia Induced by an Anti-EGFR (OPTIMAG) (OPTIMAG)

Metastatic Colorectal Cancer | Metastatic Head and Neck Cancer

France
Hoffmann-La Roche

Completed

A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)

Breast Cancer | Solid Tumor | Cancer of Head and Neck

Spain, United States, Belgium, Denmark, France, United Kingdom, Canada, Netherlands, Italy
University Hospital, Caen

Completed

Performance of PET 18 F-FDG Coupled to CT With Contrast Injection Iodized in the Diagnosis of Early Recurrences of Head and Neck Carcinoma Treated With Concurrent Chemoradiation. Comparison With 18F-FDG PET Coupled With CT Not Injected With Filling CT Standard Injection (TEPVAD)

Squamous Cell Carcinoma of the Head and Neck

France

3

Subscribe